“…E2 (250 ng dissolved in 0.1 mL of peanut oil; Sigma-Aldrich Co., St Louis, MO) and/or P (2 mg dissolved in 0.1 mL of peanut oil; Sigma-Aldrich Co.) were administered subcutaneously to some of the OVX mice, at 1,000 h for five consecutive days [9,10]. Three days before sampling, the GnRH antagonist cetrorelix (10 µg in 0.2 mL saline/daily, S.C.; Cetrotide, Merck KGaA, Darmstadt, Germany) was administered subcutaneously to some of the OVX mice, at 1,000 h for three consecutive days [11]. Six days after ovariectomy, the mice were decapitated between 1,000 and 1,200 h, and their pituitary glands and uteri were collected for RNA extraction and wet weight measurements, respectively.…”